Aoxing Pharmaceutical AOXG Stock
Aoxing Pharmaceutical Price Chart
Aoxing Pharmaceutical AOXG Financial and Trading Overview
| Aoxing Pharmaceutical stock price | 0.0023 USD |
| Previous Close | 0.0023 USD |
| Open | 0.0022 USD |
| Bid | 0.0023 USD x 3890000 |
| Ask | 0.003 USD x 6000000 |
| Day's Range | 0.0022 - 0.0022 USD |
| 52 Week Range | 0.0011 - 0.0088 USD |
| Volume | 500 USD |
| Avg. Volume | 3.22K USD |
| Market Cap | 876.78K USD |
| Beta (5Y Monthly) | -78.045 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
AOXG Valuation Measures
| Enterprise Value | 19.8M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.029123792 |
| Price/Book (mrq) | 0.009163347 |
| Enterprise Value/Revenue | 0.658 |
| Enterprise Value/EBITDA | 10.133 |
Trading Information
Aoxing Pharmaceutical Stock Price History
| Beta (5Y Monthly) | -78.045 |
| 52-Week Change | -73.86% |
| S&P500 52-Week Change | 17.31% |
| 52 Week High | 0.0088 USD |
| 52 Week Low | 0.0011 USD |
| 50-Day Moving Average | 0.00253 USD |
| 200-Day Moving Average | 0.00405325 USD |
AOXG Share Statistics
| Avg. Volume (3 month) | 3.22K USD |
| Avg. Daily Volume (10-Days) | 60 USD |
| Shares Outstanding | 381.21M |
| Float | 46.19M |
| Short Ratio | 0.03 |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | 13.24K |
| Short % of Float | 0.029% |
| Short % of Shares Outstanding | 0.020% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:2 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2016 |
| Most Recent Quarter (mrq) | March 31, 2017 |
| Next Fiscal Year End | June 30, 2017 |
Profitability
| Profit Margin | -4.86% |
| Operating Margin (ttm) | 15.40% |
| Gross Margin | 76.18% |
| EBITDA Margin | 6.48% |
Management Effectiveness
| Return on Assets (ttm) | 0.99% |
| Return on Equity (ttm) | -7.56% |
Income Statement
| Revenue (ttm) | 30.11M USD |
| Revenue Per Share (ttm) | 0.4 USD |
| Quarterly Revenue Growth (yoy) | -13.10% |
| Gross Profit (ttm) | 22.94M USD |
| EBITDA | 1.95M USD |
| Net Income Avi to Common (ttm) | -1463304 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | -78.79% |
Balance Sheet
| Total Cash (mrq) | 7.08M USD |
| Total Cash Per Share (mrq) | 0.09 USD |
| Total Debt (mrq) | 27.72M USD |
| Total Debt/Equity (mrq) | 153.29 USD |
| Current Ratio (mrq) | 0.792 |
| Book Value Per Share (mrq) | 0.251 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1363572 USD |
| Levered Free Cash Flow (ttm) | 264.82K USD |
Profile of Aoxing Pharmaceutical
| Country | United States |
| State | CA |
| City | Foster City |
| Address | 1098 Foster City Blvd |
| ZIP | 94404 |
| Phone | 646 367 1747 |
| Website | https://axzyen.icm.cn |
| Industry | Shell Companies |
| Sector(s) | Financial Services |
| Full Time Employees | 346 |
Aoxing Pharmaceutical Company, Inc. a specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People's Republic of China. The company's principal products include Zhongtong'an, a capsule of herbal extraction for the indication of oral and dental pain; and Yiqi Qiangshen Granule, an OTC herbal extraction for tonifying qi and empowering body, and promoting blood circulation to remove meridian obstruction, as well as Tilidine hydrochloride, an orally-absorbed synthetic narcotic analgesic tablet used in 50mg or 100mg dosage for relief of acute, moderate to severe pain, and chronic cancer-related pain. Its products under development comprise Oxycodone and Acetaminophen tablets and capsules, which has completed clinical trials for the treatment of acute and chronic pain; Buprenorphine/Naloxone, a sublingual combo tablet that has completed Phase II clinical trials for the treatment of opioid dependence; and Tilidine/Naloxone, a compound capsule which is in Phase II clinical trial to treat acute and chronic pain. The company was formerly known as China Aoxing Pharmaceutical Company, Inc. and changed its name to Aoxing Pharmaceutical Company, Inc. in March 2010. Aoxing Pharmaceutical Company, Inc. was incorporated in 1996 and is based in Foster City, California.
Q&A For Aoxing Pharmaceutical Stock
What is a current AOXG stock price?
Aoxing Pharmaceutical AOXG stock price today per share is 0.0023 USD.
How to purchase Aoxing Pharmaceutical stock?
You can buy AOXG shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Aoxing Pharmaceutical?
The stock symbol or ticker of Aoxing Pharmaceutical is AOXG.
Which industry does the Aoxing Pharmaceutical company belong to?
The Aoxing Pharmaceutical industry is Shell Companies.
How many shares does Aoxing Pharmaceutical have in circulation?
The max supply of Aoxing Pharmaceutical shares is 381.21M.
What is Aoxing Pharmaceutical Price to Earnings Ratio (PE Ratio)?
Aoxing Pharmaceutical PE Ratio is now.
What was Aoxing Pharmaceutical earnings per share over the trailing 12 months (TTM)?
Aoxing Pharmaceutical EPS is 0 USD over the trailing 12 months.
Which sector does the Aoxing Pharmaceutical company belong to?
The Aoxing Pharmaceutical sector is Financial Services.
